✦ LIBER ✦

Serum syndecan-4 is a novel biomarker for patients with chronic heart failure

✍ Scribed by Rieko Takahashi; Kazuaki Negishi; Atai Watanabe; Masashi Arai; Fumio Naganuma; Yoshiaki Ohyama; Masahiko Kurabayashi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum Syndecan-4 is a Novel Biomarker fo

✍ Rieko Takahashi; Kazuaki Negishi; Atai Watanabe; Masashi Arai; Fumio Naganuma; Y 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 39 KB

THE INCREMENTAL PROGNOSTIC POWER OF NOVE

✍ Lok, Dirk; Klip, IJsbrand; Lok, Sjoukje I.; Porte, Pieta W. Bruggink Andre de la 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 149 KB

FIBROBLAST GROWTH FACTOR 23 IS A NOVEL B

✍ Imazu, Miki; Asakura, Masanori; Takahama, Hiroyuki; Nakano, Atsushi; Funada, Aki 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Serum microRNA-124 is a novel biomarker

✍ Wang, J.-Y; Mao, R.-C; Zhang, Y.-M; Zhang, Y.-J; Liu, H.-Y; Qin, Y.-L; Lu, M.-J; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 868 KB

Human leukocyte antigen–G is upregulated

✍ Ali Almasood; Rohit Sheshgiri; Jemy M. Joseph; Vivek Rao; Mahsa Kamali; Laura Tu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Use of Novel and Conventional Biomarkers

✍ Kelly H. Schlendorf; Edward K. Kasper 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 225 KB